Solitary Fibrous Tumor Overview
Learn About Solitary Fibrous Tumor
Solitary fibrous tumor (SFT) is a noncancerous tumor of the lining of the lung and chest cavity, an area called the pleura. SFT used to be called localized fibrous mesothelioma.
Mesothelioma - benign; Mesothelioma - fibrous; Pleural fibroma
The exact cause of SFT remains unknown. This type of tumor affects men and women equally.
About one half of the people with this type of tumor do not show any symptoms.
If the tumor grows to a large size and pushes on the lung, it can lead to symptoms, such as:
- Chest pain
- Chronic cough
- Shortness of breath
- Clubbed appearance of the fingers
SFT is usually treated by removing the tumor.
Silvia Stacchiotti practices in Milan, Italy. Stacchiotti and is rated as an Elite expert by MediFind in the treatment of Solitary Fibrous Tumor. Her top areas of expertise are Solitary Fibrous Tumor, Adult Soft Tissue Sarcoma, Alveolar Soft Part Sarcoma, Hemangioendothelioma, and Synovectomy.
Paolo Casali practices in Milan, Italy. Casali and is rated as an Elite expert by MediFind in the treatment of Solitary Fibrous Tumor. His top areas of expertise are Adult Soft Tissue Sarcoma, Myxoid Liposarcoma, Solitary Fibrous Tumor, Pancreaticoduodenectomy, and Splenectomy.
Alessandro Gronchi practices in Milan, Italy. Gronchi and is rated as an Elite expert by MediFind in the treatment of Solitary Fibrous Tumor. His top areas of expertise are Adult Soft Tissue Sarcoma, Myxoid Liposarcoma, Liposarcoma, Pancreaticoduodenectomy, and Pancreatectomy.
The outcome is expected to be good with prompt treatment. In rare cases, the tumor may return.
Fluid escaping into the membranes around the lungs (pleural effusion) is a complication.
Contact your provider for an appointment if you notice symptoms of SFT.
Summary: The purpose of this study is to investigate the study drug, OKN4395, administered alone and in combination with pembrolizumab. The overall objectives of this study are to determine the safety and tolerability (degree to which side effects of a drug can be tolerated) of OKN4395 alone and in combination with pembrolizumab, OKN4395 and metabolites (broken-down substances) of OKN4395 levels in the blo...
Summary: This trial is a translational, open-label, multi-sites, prospective and retrospective cohort study of 500 patients aimed at clinical and biological characterization of sarcoma of rare subtype. 400 patients will be included in this prospective cohort study; they will be identified in the investigating centers in the context of either routine care or a clinical study protocol. Retrospective cases of...
Published Date: August 19, 2024
Published By: Allen J. Blaivas, DO, Division of Pulmonary, Critical Care, and Sleep Medicine, VA New Jersey Health Care System, Clinical Assistant Professor, Rutgers New Jersey Medical School, East Orange, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Kaidar-Person O, Zagar T, Haithcock BE, Weiss, J. Diseases of the pleura and mediastinum. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds. Abeloff's Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020:chap 70.
Konopka K, Arenberg DA. Benign lung tumors. In: Broaddus VC, Ernst JD, King Jr TE, et al, eds. Murray and Nadel's Textbook of Respiratory Medicine. 7th ed. Philadelphia, PA: Elsevier; 2022:chap 80.